Expand all
  • Grieve, S., Menon, P., Korgaonkar, M., Gomes, L., Foster, S., Kiernan, M., Vucic, S. (2016). Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 17 , 85-92. [More Information]
  • McKay, F., Gatt, P., Fewings, N., Parnell, G., Schibeci, S., Basuki, M., Powell, J., Goldinger, A., Fabis-Pedrini, M., Kermode, A., Burke, T., Vucic, S., Stewart, G., Booth, D. (2016). The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies. Clinical Immunology. 163 , 96-107. [More Information]

  • Ramanathan, S., Reddel, S., Henderson, A., Parratt, J., Barnett, M., Gatt, P., Merheb, V., Kumaran, R., Pathmanandavel, K., Sinmaz, N., Yiannikas, K., Vucic, S., Stewart, G., Booth, D., Dale, R., Brilot-Turville, F., et al (2014). Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurology: Neuroimmunology and Neuroinflammation. 1 (4) , 1-12. [More Information]
  • Parnell, G., Gatt, P., McKay, F., Schibeci, S., Krupa, M., Powell, J., Visscher, P., Montgomery, G., Lechner-Scott, J., Broadley, S., Liddle, C., Vucic, S., Stewart, G., Booth, D., et al (2014). Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season. Multiple Sclerosis Journal. 20 (6) , 675-685. [More Information]
  • Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology. 151 (1) , 16-24. [More Information]

    Show 1 more
  • Pride, N., Korgaonkar, M., Barton, B., Payne, J., Vucic, S., North, K. (2014). The genetic and neuroanatomical basis of social dysfunction: Lessons from neurofibromatosis type 1. Human Brain Mapping. 35 (5) , 2372-2382. [More Information]

  • Beecham, A., Patsopoulos, N., Xifara, D., Davis, M., Kempinnen, A., Cotsapas, C., Shah, T., Spencer, C., Booth, D., Goris, A., Vucic, S., Stewart, G., et al (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics. 45 (11) , 1353-1362. [More Information]
  • Cortes, A., Field, J., Glazov, E., Hadler, J., Stankovich, J., Brown, M., Baxter, A., Kermode, A., Taylor, B., Booth, D., Stewart, G., Vucic, S., et al (2013). Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Human Molecular Genetics. 22 (11) , 2283-2292. [More Information]
  • Ramanathan, S., Lenton, K., Burke, T., Gomes, L., Storchenegger, K., Yiannikas, C. and Vucic, S. (2013). The utility of multimodal evoked potentials in multiple sclerosis prognostication. Journal of Clinical Neuroscience. 1 (95) , 114-121.

  • Riveros, C., Mellor, D., Gandhi, K., McKay, F., Cox, M., Berretta, R., Vaezpour, S., Inostroza-Ponta, M., Broadley, S., Heard, R., Vucic, S., Stewart, G., Booth, D., et al (2010). A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis. PloS One. 5 (12) , e14176-1-e14176-28. [More Information]
  • Gandhi, K., McKay, F., Cox, M., Riveros, C., Armstrong, N., Heard, R., Vucic, S., Williams, D., Stankovich, J., Brown, M., Stewart, G., Booth, D., et al (2010). The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Human Molecular Genetics. 19 (11) , 2134-2143. [More Information]